The present invention relates to a novel composition for suppressing transfer activity of cancer cells. The purpose of the present invention is to provide a candidate material of suppressing cancer metastasis, which hinders EMT derived by TGF-beta and migration of cancer cells. To this end, provided is a pharmaceutical composition for anti-cancer comprising a compound of chemical formula 1. According to the present invention, BIX02189 which is knows as an inhibitor of MEK5 hinders EMT derived by TGF-beta, thereby having an activity of suppressing cancer metastasis.본 발명은 신규한 암세포 전이활성 억제용 조성물에 관한 것이다.
